TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 1 | 4 | 3 | -17 | 12 | 42 | -10 | 6 |
P | %wins | 100 | 100 | 0 | 100 | 100 | 0 | 67 | |||
S | %ret | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 6 | 21 | 5 |
S | %wins | 33 | 0 | 33 | 33 | 33 | 0 | 22 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/13 16:47 | 11/15/13 | IVZ | Invesco Ltd. | D0 | Financ | InvAdv | Investment Advice | Banham John Michael Middlecott | GA | D | S | -134 | 33.79 | 33 | -4 | -18 | 18 | D | 79 | 50 | -1 | 9 | 7 | 4 | 3 | 3 | 0 | 1 | 2 | 1 | 5 | 21 | |
5/14/13 11:02 | 5/10/13 | IVZ | Invesco Ltd. | D0 | Financ | InvAdv | Investment Advice | Banham John Michael Middlecott | GA | D | S | -287 | 33.72 | 33 | -9 | -29 | 21 | D | 46 | 51 | 45 | 25 | 18 | 15 | 7 | 3 | 1 | 2 | -2 | -4 | -1 | 9 | |
8/28/12 14:34 | 8/24/12 | IVZ | Invesco Ltd. | D0 | Financ | InvAdv | Investment Advice | Banham John Michael Middlecott | GA | D | S | -55 | 23.51 | 33 | -2 | -8 | 27 | D | 35 | 42 | -4 | 8 | 8 | 3 | -1 | -1 | 1 | 1 | 4 | 6 | 15 | 34 | |
9/8/06 16:39 | 9/7/06 | CYCC | Cyclacel Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Banham John Michael Middlecott | NJ | D | P | 21 | 5.86 | 0 | 4 | 10 | 37 | D | -87 | -10 | -21 | -15 | -9 | 2 | 14 | 18 | 4 | 3 | -17 | 12 | 42 | -10 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |